Lindus Health raises €49.5M Series B round

22 January 2025· London, United Kingdom· health, clinical_trials, ai, pure_software, b2b

To further develop its AI technology and eClinical platform, Citrus™, to optimise study design, automate central monitoring of study data, enable instant biostatistics, and more, as well as hiring in key areas including clinical operations and product development.

Investors

LeadBalderton Capital

Also participating

SeedcampVisionaries ClubCreandumFirstminute

About Lindus Health

Stage

Series B

Headquarters

London, United Kingdom

Founded

2021

Team Size

51–200

Sectors

healthclinical_trialsaipure_softwareb2b

https://www.lindushealth.com/

Source: https://www.balderton.com/news/lindus-health-raises-55m-to-transform-the-clinical-trial-landscape/